Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Aug 20;12(8):2017.
doi: 10.3390/diagnostics12082017.

Special Issue: Next-Generation Sequencing in Tumor Diagnosis and Treatment II

Umberto Malapelle  1 , Matteo Fassan  2   3 , Dario de Biase  4
Affiliations
Editorial

Special Issue: Next-Generation Sequencing in Tumor Diagnosis and Treatment II

Umberto Malapelle et al. Diagnostics (Basel). .

Abstract

Next-generation sequencing (NGS) allows for the sequencing of multiple genes at a very high depth of coverage [...].

PubMed Disclaimer

Conflict of interest statement

Umberto Malapelle reports personal fees (as speaker bureau or advisor) from Boehringer Ingelheim, AstraZeneca, Roche, M.S.D., Amgen, G.S.K., Merck, Diaceutics, Eli Lilly, Thermofisher, Diatech, Hedera, unrelated to the current work. Matteo Fassan has received research grants from Astellas Pharma, Macrophage Pharma and Q.E.D. Therapeutics and reports personal fees (as speaker bureau or advisor) from Astellas Pharma, M.S.D., Astra Zeneca, Piere Frabre, Roche, G.S.K., unrelated to the current work. Dario de Biase has received personal fees (as consultant and/or speaker bureau) from Boehringer Ingelheim, and Eli Lilly, unrelated to the current work.

Similar articles

See all similar articles

References

    1. Cappello F., Angerilli V., Munari G., Ceccon C., Sabbadin M., Pagni F., Fusco N., Malapelle U., Fassan M. FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint. J. Pers. Med. 2022;12:750. doi: 10.3390/jpm12050750. - DOI - PMC - PubMed
    1. de Biase D., Acquaviva G., Visani M., Sanza V., Argento C.M., De Leo A., Maloberti T., Pession A., Tallini G. Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel. Diagnostics. 2020;10:250. doi: 10.3390/diagnostics10040250. - DOI - PMC - PubMed
    1. Pisapia P., Pepe F., Baggi A., Barberis M., Galvano A., Gristina V., Mastrilli F., Novello S., Pagni F., Pasini S., et al. Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study. Crit. Rev. Oncol. Hematol. 2022;169:103525. doi: 10.1016/j.critrevonc.2021.103525. - DOI - PubMed
    1. Chougule A., Jagtap V., Nikam A., Kale S., Nambiar K., Bagayatkar P., Chandrani P., Kaushal R., Noronha V., Patil V., et al. Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in Diagnostics. Diagnostics. 2022;12:1291. doi: 10.3390/diagnostics12051291. - DOI - PMC - PubMed
    1. Malvi D., Vasuri F., Maloberti T., Sanza V., De Leo A., Fornelli A., Masetti M., Benini C., Lombardi R., Offi M.F., et al. Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel. Diagnostics. 2022;12:1058. doi: 10.3390/diagnostics12051058. - DOI - PMC - PubMed

Publication types

LinkOut - more resources